RSS

biologics

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData more

Opinion

Here, Rich Quelch, global head of marketing, Origin, looks at the challenges involved in primary packaging and delivery systems for biologics. more

Opinion

Science and technology company, Merck, has entered into a cooperation agreement with Netherlands-based InnoCore Pharmaceuticals, for a new drug delivery platform that will aim to improve patient compliance. more

News

The recently announced ‘Biosimilar Action Plan’ (BAP) from the US Food and Drug Administration (FDA) is another move by the regulatory body to achieve cost-effective pricing, according to an analyst at data and analytics company, GlobalData. more

News

iBio, has established a strategic commercial relationship with specialist in plant molecular medicine technology research and product development, CC-Pharming, for the joint development of products and manufacturing facilities in China. more

News

Here, Tony Hitchcock, technical director at Cobra Biologics and Joanne Anderson, business development director at Symbiosis, discuss the challenges associated with manufacturing for gene therapies. more

, Opinion

Here, Steve Lyon, digital lead, Communities & Content, Allied Market Research (AMR), discusses some examples of new technology in the ADC space and the ground-breaking potential this new class of drugs will have in the treatment of cancer more

Opinion

The National Institute for Health and Care Excellence (NICE) has published its positive guidance for the first selective interleukin (IL)-23 inhibitor to treat moderate to severe plaque psoriasis. more

News

The June issue of EPM magazine is available for download with all the regulars and features on biologics, solid dosage solutions, Queen’s Awards, purification & filtration, packaging, logistics & distribution. more

Latest Issue

Biopharmaceutical company, Bioasis, and Hong-Kong based biologics company, WuXi Biologics, have announced an initial strategic collaboration for the development and manufacture of xB3-001 — a candidate for the treatment of brain cancer. more

News

Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions, and Valerius Biopharma, a Swiss biopharmaceutical company, are collaborating on the development and manufacture of speciality biosimilars more

News

Biosimilar entry onto US market is slow despite implementation of the Biologics Price Competition and Innovation Act (BPCIA) by the Food and Drug Administration (FDA), according to data and analytics company, GlobalData. more

Analysis

Contract packaging and clinical supply services company, Sharp, has invested $11 million to increase its global cold storage and syringe assembly capacity in response to market demand. more

News

The inaugural bioprocessing and manufacturing event, bioLIVE, taking place between 9 and 11 October in Madrid, will introduce a biologics manufacturing and processing league table more

News

Event organisers, UBM, have reported that next month’s CPhI Japan 2018 will play host to an increased number of international generic active pharmaceutical ingredient (API) companies and suppliers. more

News

A $2 million centre of excellence in biologics manufacturing has been opened in Nanyang Polytechnic (NYP) in Singapore by global filtration, separation and purification company, Pall. more

News

Specialty biopharmaceutical group, Ferring Pharmaceuticals, has announced its 30 million CHF investment in its new biotech centre in Switzerland. more

News

The UK’s technology innovation provider for process manufacturing, the CPI, has announced that it is in the final stages of a collaboration project with the University of Edinburgh’s Roslin Institute to transform the manufacture of biologics. more

News